Edition:
United Kingdom

Chimerix Inc (CMRX.OQ)

CMRX.OQ on NASDAQ Stock Exchange Global Market

4.93USD
19 Jan 2018
Change (% chg)

-- (--)
Prev Close
$4.93
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
76,887
52-wk High
$6.63
52-wk Low
$4.18

Select another date:

Fri, Jan 5 2018

BRIEF-Chimerix Initiates Adapt Study For Oral Brincidofovir

* CHIMERIX INITIATES ADAPT STUDY FOR ORAL BRINCIDOFOVIR AND ADVANCES IV BRINCIDOFOVIR TO PATIENT STUDIES Source text for Eikon: Further company coverage:

BRIEF-Chimerix reports Q3 loss of $0.37/shr

* Q3 earnings per share view $-0.43 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Chimerix Inc files for mixed shelf of up to $250 million

* Files for mixed shelf of up to $250 million - SEC filing‍​ Source text : (http://bit.ly/2m8BtgL) Further company coverage:

BRIEF-Chimerix Inc entered into agreement with Cowen and Co

* On November 8, 2017, co entered into an at market issuance, or ATM, sales agreement with Cowen and Company LLC - SEC filing​

BRIEF-Chimerix Inc appoints Heather Knight-Trent vice president of regulatory affairs

* Chimerix appoints Heather Knight-Trent, PHARMD, as vice president of regulatory affairs Source text for Eikon: Further company coverage:

BRIEF-Chimerix reports Q2 loss per share $0.36

* Q2 earnings per share view $-0.41 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Select another date: